These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28290853)

  • 1. [Lipid-Lowering Therapy: a Look Into the Past and Prospects For the Near Future].
    Susekov AV
    Kardiologiia; 2016 Jun; 56(6):81-88. PubMed ID: 28290853
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Watanabe and Aizawa regarding article, "Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) Study".
    Watanabe H; Aizawa Y
    Circ Arrhythm Electrophysiol; 2012 Jun; 5(3):e80; author reply e81. PubMed ID: 22715246
    [No Abstract]   [Full Text] [Related]  

  • 3. Causal Effect of Lipids and Lipoproteins on Atherosclerosis: Lessons from Genomic Studies.
    Ference BA
    Cardiol Clin; 2018 May; 36(2):203-211. PubMed ID: 29609749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipidemia Part 2: Review of Dyslipidemia Treatment in Patients With Noncoronary Vascular Disease.
    Gonzalez L; Helkin A; Gahtan V
    Vasc Endovascular Surg; 2016 Feb; 50(2):119-35. PubMed ID: 26983668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a)-clinical aspects and future challenges.
    Kurt B; Soufi M; Sattler A; Schaefer JR
    Clin Res Cardiol Suppl; 2015 Apr; 10(Suppl 1):26-32. PubMed ID: 25732622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Drugs for Atherosclerosis.
    Bruikman CS; Stoekenbroek RM; Hovingh GK; Kastelein JP
    Can J Cardiol; 2017 Mar; 33(3):350-357. PubMed ID: 27993452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging therapies for atherosclerosis prevention and management.
    Chyu KY; Shah PK
    Cardiol Clin; 2011 Feb; 29(1):123-35. PubMed ID: 21257104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the treatment of atherosclerosis by linking anti-inflammatory and lipid modulating strategies.
    Zernecke A; Weber C
    Heart; 2012 Nov; 98(21):1600-6. PubMed ID: 23086996
    [No Abstract]   [Full Text] [Related]  

  • 9. Focus on atherosclerosis and lipids.
    Halasz G; Piepoli MF
    Eur J Prev Cardiol; 2020 Oct; 27(15):1571-1574. PubMed ID: 33030385
    [No Abstract]   [Full Text] [Related]  

  • 10. Reflections on a pioneer in the field of diet, lipids and vascular disease.
    Packard CJ
    Atherosclerosis; 2015 Dec; 243(2):656-7. PubMed ID: 26522437
    [No Abstract]   [Full Text] [Related]  

  • 11. From Lipids to Inflammation: New Approaches to Reducing Atherosclerotic Risk.
    Shapiro MD; Fazio S
    Circ Res; 2016 Feb; 118(4):732-49. PubMed ID: 26892970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lipoprotein and Coronary Atherosclerosis Study (LCAS) in context: assessing the benefits of lipid-lowering therapy. Introduction.
    Gotto AM
    Am J Cardiol; 1998 Sep; 82(6A):1M. PubMed ID: 9766340
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Lipidology and the Prevention of Vascular Disease: Time for Personalized Therapy.
    Brown WV
    Clin Pharmacol Ther; 2018 Aug; 104(2):269-281. PubMed ID: 29998536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical review 141: lipids and atherosclerosis: lessons learned from randomized controlled trials of lipid lowering and other relevant studies.
    Kreisberg RA; Oberman A
    J Clin Endocrinol Metab; 2002 Feb; 87(2):423-37. PubMed ID: 11836262
    [No Abstract]   [Full Text] [Related]  

  • 15. The Editor's Round Table: Current Perspectives on Triglycerides and Atherosclerosis.
    Friedewald VE; Jones PH; Mason P; Roberts R; Weintraub H
    Am J Cardiol; 2016 May; 117(10):1697-1702. PubMed ID: 27142496
    [No Abstract]   [Full Text] [Related]  

  • 16. Gender Disparity in Lipid Target Achievements in High and Very High Atherosclerotic Cardiovascular Disease Risk Patients in the Arabian Gulf.
    Al-Zakwani I; Shehab A; Al-Hinai AT; Al Mahmeed W; Arafah M; Al Tamimi O; Al Awadhi M; Al Anazi F; Amin H; Al Nemer K; Al Herz S; Metwally O; Alkhadra A; Fakhry M; Elghetany H; Medani AR; Yusufali AH; Al Jassim O; Al Hallaq O; Omar F; Baslaib AS; Al Waili K; Al Hashmi K; Athyros VG; Al Rasadi K
    Curr Vasc Pharmacol; 2017; 15(1):51-58. PubMed ID: 27697065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Reappraisal of the Lipid Hypothesis.
    DuBroff R
    Am J Med; 2018 Sep; 131(9):993-997. PubMed ID: 29752904
    [No Abstract]   [Full Text] [Related]  

  • 18. Regression of computer estimated femoral atherosclerosis after pronounced serum lipid lowering in patients with asymptomatic hyperlipidaemia.
    Olsson AG; Carlson LA; Erikson U; Hemius G; Hemmingsson A; Ruhn G
    Lancet; 1982 Jun; 1(8284):1311. PubMed ID: 6123054
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid pharmacotherapy for treatment of atherosclerosis.
    Nicholls SJ; Pisaniello AD; Kataoka Y; Puri R
    Expert Opin Pharmacother; 2014 Jun; 15(8):1119-25. PubMed ID: 24702590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series.
    Ference BA; Graham I; Tokgozoglu L; Catapano AL
    J Am Coll Cardiol; 2018 Sep; 72(10):1141-1156. PubMed ID: 30165986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.